NO-HEADLINE

Monday 14 October 1996 23:02 BST

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Gehe, one of Europe's largest drug wholesalers, declined to comment on reports it planned to sell all of its drug production units for a total of DM800m (pounds 331m). German daily newspaper Handelsblatt said Gehe planned to sell its generic-drug making units in order to focus on retail and distribution. Handelsblatt said Sandoz was interested in buying Gehe's Azupharma unit, which has sales of DM270m. Gehe also declined to comment on its effort to take over Lloyds Chemists, the British pharmacy chain.

Gehe has offered pounds 650m for Lloyds Chemists.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Stay up to date with notifications from The Independent

Thank you for registering

NO-HEADLINE

Join our commenting forum

Thank you for registering